481 Impact of elexacaftor/tezacaftor/ivacaftor dose adjustments on sweat chloride in children with cystic fibrosis: a case-series

Publication/Presentation Date

10-2025

Volume

24

Issue

2

First Page

277

Last Page

278

Disciplines

Medicine and Health Sciences | Pediatrics

Department(s)

Department of Pediatrics, Department of Pharmacy

Document Type

Article

Share

COinS